Sponsors of VMAC 2026

Scientific and medical progress can only succeed through the cooperation between industrial and university research. And conferences are the place where new ideas are inspired through personal relationships. The commitment  of sponsors and industrial partners make this concept a success in the long term.


Sponsors (15.000 €)

Sponsors (12.500 €)

Sponsors (10.000 €)

Sponsors (5.000 €)

--

Sponsors (4.000 €)

Sponsors (2.500 €)

Sponsors (2.500 €)

Namentliche Nennung der Sponsoren und Aussteller und Mitteilung der Höhe des Förderbetrags:

MSD Sharp & Dohme GmbH (5.000,00 €), Novo Nordisk Pharma GmbH (10.000,00 €), SYNLAB Holding Deutschland GmbH (2.500,00 €), Arrowhead Pharmaceuticals, lnc. (5.000,00 €), Sanofi-Aventis Deutschland GmbH (5.000,00 €), APONTIS PHARMA Deutschland GmbH & Co. KG (5.000,00 €), Lilly Deutschland GmbH (4.000,00 €), Fresenius Medical Care GmbH (2.500,00 €), Novartis Pharma GmbH (10.000,00 €), Ultragenyx Germany GmbH (10.000,00 €), Chiesi GmbH (2.500,00 €), Swedish Orphan Biovitrum GmbH (15.000,00 €), Daiichi Sankyo Deutschland GmbH (10.000,00 €), Daiichi Sankyo Deutschland GmbH (2.500,00 €) Amgen (12.500 €)


According to the FSA-Code, the sponsorship in return of advertising rights and exhibition space is posted below: